结直肠癌微环境:在确定癌症治疗点方面取得的临床前进展
Abdo Meyiah1, Faez Iqbal Khan1, Dia Aldeen Alfaki2
1Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
使用临床前模型针对结直肠癌 (CRC) 中的瘤微环境 (TME) 是开发新疗法的关键. 了解TME组件,如肌瘤和免疫细胞,可以改善CRC患者的治疗反应和治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 结肠直肠癌 (CRC) 尽管有治疗进展,但存在重大死亡挑战.
- 瘤微环境 (TME) 极大地影响CRC的生长,进展,预后和治疗反应.
- 有效的CRC疗法需要对TME复杂性的深入理解.
研究的目的:
- 审查关于调节结直肠癌中TME的临床前研究.
- 阐明CRC TME中肌细胞和免疫细胞的作用.
- 确定针对TME的新型治疗策略,以改善临床结果.
主要方法:
- 专注于用于CRC研究的体外和体内临床前模型.
- 在CRC中研究TME调制的研究分析.
- 检查针对TME组件的治疗方法.
主要成果:
- 临床前模型为TME在CRC中的作用提供了关键的见解.
- 准TME组件,如肌瘤和免疫细胞,可以提高治疗效果.
- 策略包括识别新目标,调节分子信号传递,并加强免疫治疗.
结论:
- 了解和针对CRC中的TME是一个有希望的途径,可以改善患者的治疗结果.
- 调节TME为结直肠癌的新疗法提供了潜在的治疗选择.
- 对TME调制的进一步研究对于推进CRC治疗至关重要.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
相关概念视频
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
